This Week In Weed – 26 August 2018


Murray Gray, 5, has become the first child in Scotland to take Cannabis-based medicine. Just days earlier a severe epileptic seizure resulted in him falling and cracking his head open.

Mum Karen has been fighting for years to get Murray medicinal cannabis and his doctors were recently granted a licence to prescribe epidiolex, which contains mainly CBD but also low traces of THC.

Karen flew Murray, and two other young boys who suffer from the same rare form of epilepsy, to Holland in July this year, in a bid to get him prescribed medicinal cannabis.

Brooke Adams, a five-year-old girl who takes cannabis oil to treat her epileptic seizures, has been allowed to return to school in Santa Rose, California after a judge granted a temporary stay that means she is now allowed to take the medicine in school hours.

Staff at Village Elementary School had refused to let her use the medication in classes despite California being one of 30 states where medical marijuana is legal, insisting state laws meant campuses had to ban the substance.

But Judge Charles Marson issued a temporary stay, which allows Brooke to attend class until he issues his final ruling in September or October. Under the order, a nurse is required to administer the medication if Brooke suffers a seizure in class.

Krishnan Wignarajah, the Chief Operation Officer (COO) of a company called Weedadvisor, has been having discussions with governments in the Caribbean to reform the laws surrounding the use of cannabis.

After members of his family benefited from the medicinal qualities in cannabis, Wignarajah says his mission is now to spread the truth about cannabis. He says the Caribbean region should approach the issue of cannabis legalisation as one and create a booming industry.

Hikurangi Cannabis has become the first company in New Zealand to secure a licence to grow medical cannabis. The East Coast company will create around 120 new jobs.

Chief executive Manu Caddie said he hopes New Zealand-made cannabis products will rival medicines such as Sativex.

“We’ve got great medical researchers in New Zealand, we can prove the effectiveness and safety of products and we can certainly provide it much cheaper than Sativex.”

Follow the UKCSC on social media: Facebook Instagram Twitter Reddit

Leave a Reply

Your email address will not be published. Required fields are marked *